Since CCL2 secreted by M2 macrophages is known to be associated with paclitaxel resistance in triple-negative breast cancer (TNBC), we next examined whether CCL2 secreted by THP-1 cells co-cultured with K2A-1 is involved in the paclitaxel resistance mechanism. The gene discussed is CCL2; the disease is triple-negative breast carcinoma.